A microarray study to characterize the molecular mechanism of TIMP-3-mediated tumor rejection

Molecular Therapy

Volumn 12, Issue 1, 2005, Pages 144-152

  Lam, Paula ^a   Sian Lim, Kar ^a   Mei Wang, Suk ^a   Hui, Kam M ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Apoptosis; Caspase cascade; Glioma; HSV 1 amplicon viral vectors; Microarray; TIMP 3

Indexed keywords

CASPASE; CYTOKINE; DEATH RECEPTOR; GROWTH FACTOR; INTERLEUKIN 1BETA CONVERTING ENZYME; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GLIOMA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; RECEPTOR UPREGULATION; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR REJECTION; XENOGRAFT;

ADAM PROTEINS; ANIMALS; APOPTOSIS; CASPASES; CELL LINE; GENE EXPRESSION PROFILING; GENETIC VECTORS; GLIOMA; HERPESVIRUS 1, HUMAN; HUMANS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

HUMAN HERPESVIRUS 1;

EID: 20844459387     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.02.028     Document Type: Article

References (42)

1. W.G. Stetler-Stevenson L.A. Liotta and D.E. Kleiner Jr. Extracellular matrix. 6. Role of matrix metalloproteinases in tumor invasion and metastasis FASEB J. 7 1993 1434-1441
2. H. Birkedal-Hansen et al. Matrix metalloproteinases: A review Crit. Rev. Oral Biol. Med. 4 1993 197-250
3. H. Nagase Activation mechanisms of matrix metalloproteinases Biol. Chem. 378 1997 151-160
4. C.E. Brinckerhoff and L.M. Matrisian Matrix metalloproteinases: A tail of a frog that became a prince Nat. Rev. Mol. Cell. Biol. 3 2003 207-214
5. S. Hernandez-Barrantes et al. Regulation of membrane type-matrix metalloproteinases Semin. Cancer Biol. 12 2002 131-138
6. S.K. Chintala J.C. Tonn and J.S. Rao Matrix metalloproteinases and their biological function in human gliomas Int. J. Dev. Neurosci. 5-6 1999 495-502
7. Y. Jiang I.D. Goldberg and Y.E. Shi Complex roles of tissue inhibitors of metalloproteinases in cancer Oncogene 21 2002 2245-2252
8. C.V. Hojilla F.F. Mohammed and R. Khokha Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development Br. J. Cancer 89 2003 1817-1821
9. D.E. Gomez D.F. Alonso H. Yoshiji and U.P. Thorgeirsson Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions Eur. J. Cell Biol. 74 1997 111-122
10. K. Brew D. Dinakarpandian and H. Nagase Tissue inhibitors of metalloproteinases: Evolution, structure and function Biochim. Biophys. Acta 1477 2000 267-283
11. A.H. Baker D. Edwards and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J. Cell Sci. 115 2002 3719-3727
12. A. Amour et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3 FEBS Lett. 435 1998 39-44
13. G. Li R. Fridman and H.R. Kim Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells Cancer Res. 59 1999 6267-6275
14. P. Valente et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis Int. J. Cancer 75 1998 246-253
15. Y. Jiang et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery Cancer Res. 61 2001 2365-2370
16. B. Anand-Apte et al. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth Biochem. Cell Biol. 74 1996 853-862
17. M.R. Smith H. Kung S.K. Durum N.H. Colburn and Y. Sun TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells Cytokine 9 1997 770-780
18. P.G. Hargreaves et al. Human myeloma cells shed the interleukin-6 receptor: Inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor Br. J. Haematol. 101 1998 694-702
19. M. Ahonen et al. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors Oncogene 22 2003 2121-2134
20. M. Bond G. Murphy M.R. Bennett A.C. Newby and A.H. Baker Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway J. Biol. Chem. 277 2002 13787-13795
21. I.L. Smith M.A. Hardwicke and R.M. Sandri-Goldin Evidence that the herpes simplex virus immediate protein ICP27 acts post-transcriptionally during infection to regulate gene expression Virology 186 1992 74-86
22. I.A.W. Ho K.M. Hui and P.Y.P. Lam Glioma-specific and cell cycle regulated HSV-1 amplicon viral vector Hum. Gene Ther. 15 2004 495-508
23. Y. Saeki X.O. Breakefield and E.A. Chiocca Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA Methods Mol. Med. 76 2003 51-60
24. G. Bergers K. Javaherian and K.M. Lo Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 284 1999 808-812
25. M.G. Tan et al. Cloning and identification of hepatocellular carcinoma down regulated mitochondrial carrier protein, a novel liver-specific uncoupling protein J. Biol. Chem. 279 2004 45235-45244
26. A. Amour et al. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3 FEBS Lett. 473 2000 275-279
27. F. Loechel J.W. Fox G. Murphy R. Albrechtsen and U.M. Wewer ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3 Biochem. Biophys. Res. Commun. 278 2000 511-515
28. M. Kashiwagi M. Tortorella H. Nagase and K. Brew TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5) J. Biol. Chem. 276 2001 12501-12504
29. K. Kuno Y. Terashima and K. Matsushima ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix J. Biol. Chem. 274 1999 18821-18826
30. R.A. Black et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells Nature 385 1997 729-733
31. J.J. Peschon et al. An essential role for ectodomain shedding in mammalian development Science 282 1998 1281-1284
32. P.A. Klenotic et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1): Implications for macular degenerations J. Biol. Chem. 279 2004 30469-30473
33. R. Timpl et al. Fibulins: A versatile family of extracellular matrix proteins Nat. Rev. Mol. Cell. Biol. 4 2003 479-489
34. Z. Werb ECM and cell surface proteolysis: Regulating cellular ecology Cell 91 1997 439-442
35. J.H. Qi et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): Inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Nat. Med. 9 2003 407-415
36. S.L. Sallinen et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques Cancer Res. 60 2000 6617-6622
37. T. Beissbarth and T.P. Speed GOstata: Find statistically overrepresented gene ontologies within a group of genes Bioinformatics 20 2004 1464-1465
38. A. Degterev M. Boyce and J. Yuan A decade of caspases Oncogene 22 2003 8543-8567
39. M. Ahonen et al. Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3 Mol. Ther. 5 2002 705-715
40. P. Gonzalez-Gomez et al. Promoter methylation status of multiple genes in brain metastases of solid tumors Int. J. Mol. Med. 13 2004 93-98
41. P. Gonzalez-Gomez et al. Promoter hypermethylation of multiple genes in astrocytic gliomas Int. J. Oncol. 22 2003 601-608
42. K.E. Bachman et al. Methylation associated silencing of the tissue inhibitor of metalloproteinase 3 gene suggests a suppressor role in kidney, brain, and other human cancers Cancer Res. 59 1999 798-802